www.cancertherapyadvisor.com Open in urlscan Pro
2606:4700::6812:3ad  Public Scan

Submitted URL: https://app.info.haymarketmedicalnetwork.com/e/er?s=2255121&lid=25963&elqTrackId=b4e311850393474bab780a72171f7f3e&utm_campaign=NWLTR_CTA_UPDT...
Effective URL: https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/lidocaine-peritumoral-injection-breast-cancer-surgery-improves-...
Submission: On April 25 via manual from US — Scanned from DE

Form analysis 4 forms found in the DOM

https://www.cancertherapyadvisor.com/

<form class="search focus-label" id="mobile-search" aria-hidden="true" action="https://www.cancertherapyadvisor.com/" aria-expanded="false">
  <input class="searchinput predictive-search" id="q" type="text" value="" name="s">
  <label class="searchformlabel " id="q-label" for="q"> Search... </label>
  <button class="submit" type="submit">
    <span class="searchicon">
      <svg role="presentation" class="icon icon--search" aria-label="search">
        <use xlink:href="https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1666876545#search"></use>
      </svg> </span>
    <span class="screen-reader-text">Submit</span>
  </button>
</form>

<form class="HMIRegistration__form" novalidate="">
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="email" id="root_subscriber_email" label="email" placeholder="*E-mail Address" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control ">
        <div id="cntry" class="HMIRegistration__select"><select id="*Country" class="HMIRegistration__select">
            <option value="">*Country</option>
            <option value="US">United States</option>
          </select>
          <div class="HMIRegistration__select--down-caret"><svg width="14 " height="12" class="widget-svg">
              <polygon class="down-caret" points="7 12, 14 0, 0 0"></polygon>
            </svg></div>
        </div>
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control--checkbox ">
        <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite ismedical"><span class="HMIRegistration__sprite-border u-active"></span><span class="HMIRegistration__sprite-checkmark u-active"><svg width="15" height="15"
                class="widget-svg">
                <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
              </svg></span><span class="HMIRegistration__sprite-fill u-active"></span></span><span class="HMIRegistration__text u-active">Cancer Therapy Advisor Weekly Highlights</span></div>
      </div>
      <div class="HMIRegistration__form-control--checkbox ">
        <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite ismedical"><span class="HMIRegistration__sprite-border u-active"></span><span class="HMIRegistration__sprite-checkmark u-active"><svg width="15" height="15"
                class="widget-svg">
                <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
              </svg></span><span class="HMIRegistration__sprite-fill u-active"></span></span><span class="HMIRegistration__text u-active">Cancer Therapy Advisor Daily Update</span></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row HMIRegistration__opt-in-email">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite"><span class="HMIRegistration__sprite-border "></span><span class="HMIRegistration__sprite-checkmark "><svg width="15" height="15" class="widget-svg">
              <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
            </svg></span><span class="HMIRegistration__sprite-fill "></span></span><span class="HMIRegistration__text ">I would like to receive relevant information via email from Cancer Therapy Advisor / Haymarket Medical Network.</span></div>
    </div>
  </div>
  <div class="HMIRegistration__row HMIRegistration__opt-in-email">
    <div class="HMIRegistration__column u-col12">By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our
      <a href="https://www.haymarketmediaus.com/haymarket-media-inc-privacy-policy/ " target="_blank" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">privacy policy</a> and
      &nbsp;<a href="https://www.haymarketmediaus.com/haymarket-media-inc-terms-and-conditions-of-service/" target="_blank" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">terms and conditions</a></div>
  </div><button class="HMIRegistration__submit" type="submit">Sign Up</button>
  <div class="HMIRegistration__us_privacy-policy privacy__terms" id="newsletter-asset">
    <a href="https://www.haymarketmediaus.com/haymarket-media-inc-privacy-policy/" target="_blank" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">Privacy Policy</a> &nbsp;|
    &nbsp;<a href="https://www.haymarketmediaus.com/haymarket-media-inc-terms-and-conditions-of-service/" target="_blank" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">Terms &amp; Conditions</a></div>
</form>

<form class="HMIRegistration__form ismedical" novalidate="">
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="email" id="root_email" label="email" placeholder="*E-mail Address" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="password" id="root_password" label="password" placeholder="*Password" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite"><span class="HMIRegistration__sprite-border "></span><span class="HMIRegistration__sprite-checkmark "><svg width="15" height="15" class="widget-svg">
              <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
            </svg></span><span class="HMIRegistration__sprite-fill "></span></span><span class="HMIRegistration__text ">Keep me signed in</span></div>
    </div>
  </div>
  <p class="HMIRegistration__text linkToForgetPword ismedical"><a href="#" class="HMIRegistration__link ismedical" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">Forgot your password?</a></p><button
    class="HMIRegistration__submit ismedical" type="submit">Login</button>
  <p class="HMIRegistration__text goToRegister ismedical">
    <a href="#" class="HMIRegistration__link ismedical" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">Do not have an account yet?<strong> Register</strong></a></p>
</form>

<form class="HMIRegistration__form ismedical" novalidate="">
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="email" id="root_email" label="email" placeholder="*E-mail Address" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="password" id="root_password" label="password" placeholder="*Password" value="">
        <div></div>
      </div>
    </div>
  </div>
  <div class="HMIRegistration__row ">
    <div class="HMIRegistration__column u-col12">
      <div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite"><span class="HMIRegistration__sprite-border "></span><span class="HMIRegistration__sprite-checkmark "><svg width="15" height="15" class="widget-svg">
              <path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
            </svg></span><span class="HMIRegistration__sprite-fill "></span></span><span class="HMIRegistration__text ">Keep me signed in</span></div>
    </div>
  </div>
  <p class="HMIRegistration__text linkToForgetPword ismedical"><a href="#" class="HMIRegistration__link ismedical" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">Forgot your password?</a></p><button
    class="HMIRegistration__submit ismedical" type="submit">Login</button>
  <p class="HMIRegistration__text goToRegister ismedical">
    <a href="#" class="HMIRegistration__link ismedical" data-feathr-click-track="true" data-feathr-link-aids="[&quot;5ac50f6bf60e8103ce30c554&quot;]">Do not have an account yet?<strong> Register</strong></a></p>
</form>

Text Content

Skip to navigation Skip to main content
Menu Close
Search... Submit
 * Breast
 * CML
 * Gastrointestinal
 * GYN
 * Lung
 * Multiple Myeloma
 * Prostate
 * RCC
 * Skin
 * MoreOpen Submenu
   * More Back
      * Bladder Cancer
      * Bone Cancer
      * Brain Cancer
      * Chronic Lymphocytic Leukemia
     
      * Endocrine Cancer
      * General Medicine
      * General Oncology
      * Head and Neck Cancer
      * Hematologic Cancers
     
      * Lymphoma
      * Pancreatic Cancer
      * Pediatric Cancer
      * Practice Management
     
      * Sarcoma
      * Supportive Care
      * Urologic Cancers

Toggle Search Menu
 * Headlines
 * Regimens
 * Drugs
 * Conferences
 * Clinical Resources
 * Tools
 * Multimedia
 * CME
 * Jobs

Advertisement


Login Register
 * Get the App
 * Submit Cases

 * 
 * 
 * 

Home » Cancer Topics » Breast Cancer

Publish Date April 24, 2023


PERITUMORAL LIDOCAINE INJECTION BEFORE BREAST CANCER SURGERY IMPROVES OUTCOMES

Laura M. Healy

 * Share on Facebook
 * Share on Twitter
 * Share on LinkedIn
 * Share on Reddit
 * Print
 * Share by Email

The 5-year overall survival rate was 90.1% for patients who received lidocaine
and 86.4% for those who did not. Source: Getty Images


Breast cancer patients who receive a peritumoral injection of lidocaine
immediately before surgery have better survival outcomes, according to research
published in the Journal of Clinical Oncology.

The injection significantly increased disease-free survival (DFS) and overall
survival (OS) in patients with early operable breast cancer who did not receive
neoadjuvant treatment, researchers found.

In this open-label, randomized, phase 3 trial (ClinicalTrials.gov Identifier:
NCT01916317), researchers analyzed the potential antimetastatic effects of local
anesthesia injections 7-10 minutes before scheduled surgery for early breast
cancer.





Today’s top picks on the Haymarket Medical Network
More Lines of Chemotherapy Linked to Higher Risk of VTE in Ovarian CancerJessica
Nye, PhDMarch 31, 2023
Adavosertib Appears Active but Toxic in Advanced Uterine CancerJessica Nye,
PhDMarch 28, 2023
Insurance Status Mediates Racial, Ethnic Inequities in Cervical CancerHaymarket
MediaMarch 13, 2023

--------------------------------------------------------------------------------

Continue Reading




The study included 1583 evaluable breast cancer patients who were separated into
2 groups — those who received a peritumoral injection of 0.5% lidocaine
immediately before surgery (n=786) and those who did not (n=797). Baseline
characteristics were well balanced between the arms.

The median follow-up was 69 months, and the primary endpoint was DFS. The 5-year
DFS rate was 86.6% for lidocaine recipients and 82.6% for patients who did not
receive lidocaine (hazard ratio [HR], 0.74; 95% CI, 0.58-0.95; P =.017). 

The 5-year cumulative incidence of locoregional recurrence was 3.2% for
lidocaine recipients and 4.1% for the control group (subdistribution HR [SHR],
0.69; 95% CI, 0.42-1.13). The 5-year distant recurrence rate was 8.1% and 10.9%,
respectively (SHR, 0.74; 95% CI, 0.54-1.01).

The 5-year OS rate was 90.1% for lidocaine recipients and 86.4% for patients who
did not receive lidocaine (HR, 0.71; 95% CI, 0.53-0.94; P =.019).

There were no adverse events related to lidocaine.

“In summary, peritumoral injection of lidocaine before breast cancer surgery
significantly increases DFS and OS,” the researchers concluded. “Altering events
at the time of surgery can prevent metastases in early breast cancer, and more
such interventions need to be explored in future studies.”

Disclosures: One study author declared affiliations with biotech,
pharmaceutical, and/or device companies. Please see the original reference for a
full list of disclosures.

Reference

Badwe RA, Parmar V, Nair N, et al. Effect of peritumoral infiltration of local
anesthetic before surgery on survival in early breast cancer. J Clin Oncol.
Published online April 6, 2023. doi:10.1200/JCO.22.01966



TOPICS:

Breast Cancer


 * GET CANCER THERAPY ADVISOR IN YOUR INBOX
   
   Sign up to get the latest cancer therapy news in your inbox.
   
   *CountryUnited States
   
   
   Cancer Therapy Advisor Weekly Highlights
   Cancer Therapy Advisor Daily Update
   I would like to receive relevant information via email from Cancer Therapy
   Advisor / Haymarket Medical Network.
   By registering you consent to the collection and use of your information to
   provide the products and services you have requested from us and as described
   in our privacy policy and  terms and conditions
   Sign Up
   Privacy Policy  |  Terms & Conditions

 * Registered users get free access to premium features like:
   
    * A personalized onsite experience
    * Your top three articles, curated onsite daily
    * Unlimited access to our expert content
   
   REGISTER
   
   Already have an account? Sign in here

 * 
 * Loading...
   
   Popular in Cancer Therapy
   
   siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com
   siteID 12 Pfizer-BioNTech Bivalent Booster Authorized for Kids Under 5 Years
   Diana Ernst, RPh 17 March 2023 cancertherapyadvisor.com Young children are
   now eligible to receive the booster dose at least 2 months after they
   complete primary vaccination wi… siteName Cancer Therapy Advisor siteURL
   https://www.cancertherapyadvisor.com siteID 12 Pentagon Study Finds Higher
   Cancer Rates Among Pilots, Ground Crews Haymarket Media 23 March 2023
   cancertherapyadvisor.com Military pilots and the ground crews who fuel and
   maintain their aircraft have higher rates of certain cancers, a new study
   shows. siteName Cancer Therapy Advisor siteURL
   https://www.cancertherapyadvisor.com siteID 12 AFM13 Proves Active in
   Relapsed/Refractory PTCL, Especially AITL Andrea S. Blevins Primeau, PhD, MBA
   19 April 2023 cancertherapyadvisor.com The bispecific antibody AFM13 elicits
   responses in patients with relapsed/refractory peripheral T-cell lymphoma, a
   phase 2 study suggests. siteName Cancer Therapy Advisor siteURL
   https://www.cancertherapyadvisor.com siteID 12 Adding Anlotinib to
   Pembrolizumab Improves PFS in Ovarian Cancer Caleb Rans 28 March 2023
   cancertherapyadvisor.com Anlotinib enhances the efficacy of pembrolizumab in
   patients with recurrent or refractory high-grade serous ovarian canc…
   siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com
   siteID 12 Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ
   Recipients Haymarket Media 22 March 2023 cancertherapyadvisor.com Oral
   nicotinamide does not reduce the risk of keratinocyte cancers in organ
   transplant recipients, a study suggests. siteName Cancer Therapy Advisor
   siteURL https://www.cancertherapyadvisor.com siteID 12 Responses Fleeting
   With CAR-T Reinfusion in Children, AYAs With B-ALL Laura M. Healy 27 February
   2023 cancertherapyadvisor.com Reinfusion with the CAR T-cell therapy
   tisagenlecleucel does not produce durable remissions in children and AYAs
   with B-…
 * 
 * Loading...
   
   Continuing Medical Education (CME/CE) Courses
   
   siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com
   siteID 12 The Brigham and Dana-Farber Board Review and Comprehensive Update
   in Oncology for NPs and PAs Haymarket Media 18 April 2023 mycme.com siteName
   Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12
   Leveraging Expert-Informed Adverse Event Management and Supportive Care
   Strategies to Improve Patient Outcomes in Bladder Cancer Haymarket Media 29
   March 2023 mycme.com siteName Cancer Therapy Advisor siteURL
   https://www.cancertherapyadvisor.com siteID 12 Advances of Immunotherapies in
   Autoimmune Neuromuscular Disease: Targeting B cells, Complement and FcRn
   Haymarket Media 1 April 2023 mycme.com siteName Cancer Therapy Advisor
   siteURL https://www.cancertherapyadvisor.com siteID 12 What Would You Do
   Next? Case-based Strategies in Moderate-to-Severe Asthma Haymarket Media 20
   April 2023 mycme.com siteName Cancer Therapy Advisor siteURL
   https://www.cancertherapyadvisor.com siteID 12 The Patient Journey in ADHD:
   What Can You Do to Alter the Course? Haymarket Media 4 April 2023 mycme.com
   siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com
   siteID 12 What My Mistakes Taught Me Haymarket Media 19 April 2023 mycme.com
   
   Show More

 * 


WANT TO READ MORE?

Please login or register first to view this content.

Login Register


Open
Next post in Breast Cancer Close


LOW RECURRENCE RISK WITH BREAST-CONSERVING THERAPY IN MULTIPLE IPSILATERAL
BREAST CANCER

Back to Top

 * CancerTherapyAdvisor.com is a free online resource that offers oncology
   healthcare professionals a comprehensive knowledge base of practical oncology
   information and clinical tools to assist in making the right decisions for
   their patients.
   
   Our mission is to provide practice-focused clinical and drug information that
   is reflective of current and emerging principles of care that will help to
   inform oncology decisions.

 * Do Not Sell or Share My Personal Information

 * 
 * 
 * 

 * RESOURCES
   
    * Submissions
    * Advisory Board
    * Useful Links
    * Reprints/Permissions

 * USER CENTER
   
    * About Us
    * Advertise
    * Contact Us
    * Staff

 * OTHER HAYMARKET MEDICAL WEBSITES
   
    * Clinical Advisor
    * Clinical Pain Advisor
    * Dermatology Advisor
    * Endocrinology Advisor
    * Gastroenterology Advisor
    * Hematology Advisor
    * Infectious Disease Advisor
    * McKnight’s Long Term Care News
    * McKnight’s Senior Living
    * Medical Bag
    * MPR
    * myCME
    * Neurology Advisor
    * Oncology Nurse Advisor
    * Ophthalmology Advisor
    * Optometry Advisor
    * Psychiatry Advisor
    * Pulmonology Advisor
    * Rare Disease Advisor
    * Renal and Urology News
    * Rheumatology Advisor
    * The Cardiology Advisor

 * Copyright © 2023 Haymarket Media, Inc. All Rights Reserved
   This material may not be published, broadcast, rewritten or redistributed in
   any form without prior authorization.
   Your use of this website constitutes acceptance of Haymarket Media’s Privacy
   Policy and Terms & Conditions.

Some areas of this page may shift around if you resize the browser window. Be
sure to check heading and document order.
Close more info about Peritumoral Lidocaine Injection Before Breast Cancer
Surgery Improves Outcomes


LOG IN TO CANCER THERAPY ADVISOR




PLEASE LOG IN USING YOUR PASSWORD.

*Required
Keep me signed in

Forgot your password?

Login

Do not have an account yet? Register


Close more info about Peritumoral Lidocaine Injection Before Breast Cancer
Surgery Improves Outcomes


JOIN THE




CREATING YOUR FREE ACCOUNT WITH CANCER THERAPY ADVISOR ALLOWS YOU ACCESS TO
EXCLUSIVE CONTENT, INCLUDING CASE STUDIES, DRUG INFORMATION, CME AND MORE ACROSS
OUR GROWING NETWORK OF CLINICAL SITES.

*Required
*ProfessionCertified Diabetes EducatorClinical Nurse SpecialistConsumer /
PatientDentistDietitian / NutritionistGenetic CounselorNurseNurse
PractitionerOther Healthcare ProfessionalPharmacistPhysicianPhysician
AssistantPsychologistResidentStudent

*SpecialtyAllergy / ImmunologyAnesthesiologyBariatric
MedicineCardiologyComplementary / Alternative MedicineCritical Care
MedicineDentalDermatologyDiabetesEmergency MedicineEndocrinologyFamily Medicine
/ General PracticeGastroenterology / ProctologyGeriatric
MedicineHematologyHematology / OncologyHospitalistInfectious DiseaseInfusion
TherapyInternal MedicineLong-Term CareNephrologyNeurologyNutritionObstetrics /
GynecologyOncologyOphthalmologyOptometryOrthopedicsOtolaryngologyPain
MedicinePathologyPediatricsPharmacyPhysical Medicine /
RehabilitationPsychiatryPublic Health / Preventive MedicinePulmonologyRadiology
/ Nuclear MedicineRheumatologySports MedicineSurgeryUrologyOther

*CountryUnited States

--State--AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew
HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth
DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth
DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington, D.C.West
VirginiaWisconsinWyoming


REGISTER FOR EMAIL NEWSLETTERS

Cancer Therapy Advisor Weekly Highlights
Cancer Therapy Advisor Daily Update
Register

Already have an account with one of our brands? LOG IN

Terms and Conditions | Privacy Policy


Close more info about Peritumoral Lidocaine Injection Before Breast Cancer
Surgery Improves Outcomes

You’ve read 1 of 5 articles this month.

We want you to take advantage of everything Cancer Therapy Advisor has to offer.
To view unlimited content, log in or register for free.

Login Register

Close more info about Peritumoral Lidocaine Injection Before Breast Cancer
Surgery Improves Outcomes


LOG IN TO CANCER THERAPY ADVISOR




PLEASE LOG IN USING YOUR PASSWORD.

*Required
Keep me signed in

Forgot your password?

Login

Do not have an account yet? Register


Close more info about Peritumoral Lidocaine Injection Before Breast Cancer
Surgery Improves Outcomes


JOIN THE




CREATING YOUR FREE ACCOUNT WITH CANCER THERAPY ADVISOR ALLOWS YOU ACCESS TO
EXCLUSIVE CONTENT, INCLUDING CASE STUDIES, DRUG INFORMATION, CME AND MORE ACROSS
OUR GROWING NETWORK OF CLINICAL SITES.

*Required
*ProfessionCertified Diabetes EducatorClinical Nurse SpecialistConsumer /
PatientDentistDietitian / NutritionistGenetic CounselorNurseNurse
PractitionerOther Healthcare ProfessionalPharmacistPhysicianPhysician
AssistantPsychologistResidentStudent

*SpecialtyAllergy / ImmunologyAnesthesiologyBariatric
MedicineCardiologyComplementary / Alternative MedicineCritical Care
MedicineDentalDermatologyDiabetesEmergency MedicineEndocrinologyFamily Medicine
/ General PracticeGastroenterology / ProctologyGeriatric
MedicineHematologyHematology / OncologyHospitalistInfectious DiseaseInfusion
TherapyInternal MedicineLong-Term CareNephrologyNeurologyNutritionObstetrics /
GynecologyOncologyOphthalmologyOptometryOrthopedicsOtolaryngologyPain
MedicinePathologyPediatricsPharmacyPhysical Medicine /
RehabilitationPsychiatryPublic Health / Preventive MedicinePulmonologyRadiology
/ Nuclear MedicineRheumatologySports MedicineSurgeryUrologyOther

*CountryUnited States

--State--AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew
HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth
DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth
DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington, D.C.West
VirginiaWisconsinWyoming


REGISTER FOR EMAIL NEWSLETTERS

Cancer Therapy Advisor Weekly Highlights
Cancer Therapy Advisor Daily Update
Register

Already have an account with one of our brands? LOG IN

Terms and Conditions | Privacy Policy



You’ve read {{metering-count}} of {{metering-total}} articles this month.

We want you to take advantage of everything Cancer Therapy Advisor has to offer.
To view unlimited content, log in or register for free.

{{login-button}} {{register-button}}

Want to view more content from Cancer Therapy Advisor?

Register now at no charge to access unlimited clinical news, full-length
features, case studies, conference coverage, and more.

{{login-button}} {{register-button}}


WANT TO READ MORE?

Please login or register first to view this content.

Login Register


word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word

mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1


DO NOT SELL OR SHARE MY PERSONAL DATA

When you visit our website, we store cookies on your browser to collect
information. The information collected might relate to you, your preferences or
your device, and is mostly used to make the site work as you expect it to and to
provide a more personalized web experience. However, you can choose not to allow
certain types of cookies, which may impact your experience of the site and the
services we are able to offer. Click on the different category headings to find
out more and change our default settings according to your preference. You
cannot opt-out of our First Party Strictly Necessary Cookies as they are
deployed in order to ensure the proper functioning of our website (such as
prompting the cookie banner and remembering your settings, to log into your
account, to redirect you when you log out, etc.). For more information about the
First and Third Party Cookies used please follow this link.
More information
Accept


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms.    You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work. These cookies do not store any personally identifiable information.

 * FUNCTIONAL COOKIES
   
   Always Active
   
   These cookies enable the website to provide enhanced functionality and
   personalisation. They may be set by us or by third party providers whose
   services we have added to our pages.    If you do not allow these cookies
   then some or all of these services may not function properly.

DO NOT SELL PERSONAL INFORMATION

Do Not Sell Personal Information

 * SOCIAL MEDIA COOKIES
   
   Switch Label label
   
   These cookies are set by a range of social media services that we have added
   to the site to enable you to share our content with your friends and
   networks. They are capable of tracking your browser across other sites and
   building up a profile of your interests. This may impact the content and
   messages you see on other websites you visit.    If you do not allow these
   cookies you may not be able to use or see these sharing tools.

 * PERFORMANCE COOKIES
   
   Switch Label label
   
   These cookies allow us to count visits and traffic sources so we can measure
   and improve the performance of our site. They help us to know which pages are
   the most and least popular and see how visitors move around the site.    All
   information these cookies collect is aggregated and therefore anonymous. If
   you do not allow these cookies we will not know when you have visited our
   site, and will not be able to monitor its performance.

 * TARGETING COOKIES
   
   Switch Label label
   
   These cookies may be set through our site by our advertising partners. They
   may be used by those companies to build a profile of your interests and show
   you relevant adverts on other sites.    They do not store directly personal
   information, but are based on uniquely identifying your browser and internet
   device. If you do not allow these cookies, you will experience less targeted
   advertising.

Back Button


PERFORMANCE COOKIES



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
Switch Label label
Switch Label label
Switch Label label

Confirm My Choices

ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789-_~

x